Detalles de la búsqueda
1.
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
Hematol Oncol
; 38(4): 541-553, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495951
2.
The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
Am J Hematol
; 93(7): 895-901, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29659040
3.
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine.
Blood Adv
; 5(1): 129-142, 2021 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570632
4.
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort study.
EJHaem
; 1(1): 255-261, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35847690
5.
Intravascular B-cell lymphoma with leukemic presentation: case report and literature review.
Eur J Haematol
; 80(2): 177-81, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18076638
6.
Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries.
Leukemia
; 37(3): 708-711, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646886
7.
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine.
Clin Cancer Res
; 22(8): 1958-68, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26700206
8.
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes.
Blood Cancer J
; 11(2): 30, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574231
9.
Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).
Mediterr J Hematol Infect Dis
; 11(1): e2019045, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31308921
10.
Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
Eur J Haematol
; 78(1): 89-90, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17302860
Resultados
1 -
10
de 10
1
Próxima >
>>